Skip to content
Search

Latest Stories

Lloyds closed and sold all its pharmacies in Wales

Lloyds Pharmacy has closed and sold its Welsh branches over "growing pressures" on the pharmacy sector 

Lloyds Pharmacy announced the withdrawal of pharmacy services from all Sainsbury’s stores over mounting "industry pressures" faced by the community pharmacies.


The company had 77 branches at the beginning of this year - out of which five branches closed their doors and transferred the ownership of the remaining 72 to others.

It was announced in June this year that Lloyds Pharmacy branches in Sainsbury's will close its operation throughout 2023.

The following decision came after "changing market conditions" put 2,000 jobs on the line across the UK.

Four Lloyds Pharmacies inside Wales Sainsbury's stores closed within days of the announcement and one in the Roath suburb of Cardiff as well.

The remaining 72 changed hands as confirmed by the figures obtained by WalesOnline on 5 October.

However, Lloyds Pharmacy has not yet updated information on the number of branches closed or the staff impacted by the decision.

The statement released by the pharmacy spokesperson read: "LloydsPharmacy is reviewing its community pharmacy estate and is selectively selling some branches.

"The majority of buyers of these selected branches are independent pharmacy owners and local businesspeople who have demonstrated their commitment to our branch teams and patients and are well-placed to meet the ongoing health needs of the local community.

"The Lloyds Pharmacy team is pleased that its colleagues from these stores will be joining successful, local businesses and that for patients there will be no change in the way they use their local pharmacy," it further read.

The figures obtained by StatsWales on 27 October confirmed that the number came down to 698 community pharmacies in Wales out of 716 - number of pharmacies in 2018-19.

The closure of Lloyds pharmacies indicates a wider issue emerging in the pharmaceutical industry.

The chain is the UK's second-largest after Boots and was acquired by Aurelius, the multinational private equity firm from Sainsbury's last year.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less